DekaBank Deutsche Girozentrale Has $182,000 Holdings in Masimo Corporation (MASI)

DekaBank Deutsche Girozentrale boosted its stake in Masimo Corporation (NASDAQ:MASI) by 78.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,106 shares of the medical equipment provider’s stock after acquiring an additional 925 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Masimo were worth $182,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MASI. Prudential Financial Inc. boosted its stake in shares of Masimo by 14.4% during the 2nd quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock valued at $50,442,000 after buying an additional 69,810 shares during the last quarter. State Street Corp boosted its stake in shares of Masimo by 10.4% during the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock valued at $141,121,000 after buying an additional 146,212 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Masimo by 98.0% during the 2nd quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock valued at $19,100,000 after buying an additional 103,656 shares during the last quarter. D L Carlson Investment Group Inc. boosted its stake in shares of Masimo by 32.4% during the 2nd quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock valued at $4,216,000 after buying an additional 11,315 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of Masimo by 27.1% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after buying an additional 233,412 shares during the last quarter. Hedge funds and other institutional investors own 84.70% of the company’s stock.

In related news, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total transaction of $900,000.00. Following the transaction, the director now directly owns 73,249 shares in the company, valued at $6,592,410. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Yongsam Lee sold 5,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total value of $449,450.00. Following the transaction, the executive vice president now owns 74,000 shares in the company, valued at $6,651,860. The disclosure for this sale can be found here. Insiders have sold 28,976 shares of company stock worth $2,599,324 over the last 90 days. 16.60% of the stock is currently owned by company insiders.

Masimo Corporation (NASDAQ MASI) opened at $87.97 on Monday. Masimo Corporation has a one year low of $60.31 and a one year high of $104.71. The stock has a market capitalization of $4,545.50, a price-to-earnings ratio of 33.70, a P/E/G ratio of 2.96 and a beta of 0.75.

Masimo (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The firm had revenue of $193.69 million for the quarter, compared to analysts’ expectations of $189.01 million. During the same period last year, the business posted $0.52 earnings per share. The firm’s revenue for the quarter was up 15.6% on a year-over-year basis. sell-side analysts forecast that Masimo Corporation will post 2.95 EPS for the current fiscal year.

Several equities analysts have recently commented on the company. BidaskClub cut Masimo from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a research note on Thursday, November 2nd. Stifel Nicolaus reiterated a “buy” rating and set a $108.00 target price (up from $105.00) on shares of Masimo in a research note on Thursday, August 3rd. Finally, BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. Masimo presently has a consensus rating of “Hold” and an average price target of $97.17.

ILLEGAL ACTIVITY NOTICE: “DekaBank Deutsche Girozentrale Has $182,000 Holdings in Masimo Corporation (MASI)” was published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://transcriptdaily.com/2017/11/27/dekabank-deutsche-girozentrale-has-182000-holdings-in-masimo-corporation-masi.html.

About Masimo

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply